The performance of the MODY calculator in a non-Caucasian, mixed-race population diagnosed with diabetes mellitus before age 35 years
Authors:
Preprint
- 11 November 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Backgroud: A maturity-onset diabetes of the young (MODY) calculator has been described and validated for use in European Caucasians. This study evaluated its performance in Brazilians diagnosed with diabetes mellitus (DM) before 35 years of age. Methods: The electronic records of 391 individuals monitored between 1953 and 2020 at the diabetes clinic of a quaternary hospital in São Paulo were analyzed: 231 with type 1 DM (T1DM), 46 with type 2 (T2DM) and 114 with MODY. The MODY calculator was applied to the three groups. A receiver operating characteristic curve was calculated to obtain cut-off points for this population. Results: The principal differences between the MODY and the T1DM and T2DM groups were body mass index, a positive family history of diabetes and mean HbA1c level. Age at diagnosis in the MODY group was only significantly different compared to the T2DM group. Specificity and sensitivity were good for the cut-off points of 40%, 50% and 60%, with the accuracy of the model for any of these cut-off points being >95%. Conclusion: The capacity of the calculator to identify Brazilian patients with MODY was good. Values ≥60% proved useful for selecting candidates for MODY genetic testing, with good sensitivity and specificity.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Targeted sequencing identifies novel variants in common and rare MODY genesMolecular Genetics & Genomic Medicine, 2019
- MODY probability calculator for GCK and HNF1A screening in a multiethnic background populationArchives of Endocrinology and Metabolism, 2019
- A systematic scoping review of the genetic ancestry of the Brazilian populationGenetics and Molecular Biology, 2019
- A systematic literature review on the European, African and Amerindian genetic ancestry components on Brazilian health outcomesScientific Reports, 2019
- ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescentsPediatric Diabetes, 2018
- The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase IIMedical Journal of Australia, 2017
- Clinical application of ACMG‐AMP guidelines in HNF1A and GCK variants in a cohort of MODY familiesClinical Genetics, 2017
- South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European peopleDiabetologia, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetesDiabetologia, 2012